1/13
NS-Baseline2020_white.png

Your  R&D
department

Neuro-Sys is a research-intensive and innovative organization specializing in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields.

Award winning CRO

World's best CRO

Corporate Live Wire 2021

NEURO-SYS INC.png

Experts in
neurodegenerative
preclinical modelling
services

Latest
news

 
20220801_104623.png

 POSTERS  August 01, 2022

Poster presentation @AAIC 2022

"Neuroinflammation and microglial activation in Alzheimer’s Disease: in vitro and in vivo models of study."

Poster # N6P42

pdf-download-3395.png
20220713_095924.jpg

 POSTERS  July 13, 2022

Poster presentation @FENS 2022

"New in vivo model of Parkinson’s disease involving combined toxicity of alpha-synuclein oligomers and protofibrils, and chronic inhibition of GBA."

Poster # N6P41

pdf-download-3395.png
FENS2022_1.png

 POSTERS  July 12, 2022

Poster presentation @FENS 2022

"Loss of GBA activity exacerbate the toxicity of alpha-synuclein oligomers and protofibrils in an in vitro model of Parkinson’s disease."

Poster # N6P40

pdf-download-3395.png
AAIC22-purple-font.jpg

 EVENT  February 03, 2022

 

Neuro-Sys will be exhibiting at AAIC in San Diego, 31 July-3 August 2022.

Booth #421

 

The Alzheimer’s Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science

> More

News_award.png

 AWARDS  August 29, 2021

 

Neuro-Sys inc. elected 2021 World's Best CRO of the year by Corporate Live Wire (UK).

We are very proud of this distinction, which congratulates several years of preclinical scientific excellence, the continuous efforts of our team of experts and the significant investments undertaken.

> More

design Book

 PUBLICATIONS  August 30, 2021

NSP01, a green extract of Huperzia serrata with neuroprotective effects related to synergistic action of Huperzine A and polyphenols

Noelle Callizot, Maria-Letizia Campanari, Laura Rouvière, Guillaume Jacquemot, Alexandre Henriques, Elnur Garayev and Philippe Poindron

> More

design Book

 PUBLICATIONS  August 19, 2021

AZP2006, a new promising treatment for Alzheimer’s and related diseases

N Callizot, C Estrella, S Burlet, A Henriques, C Brantis, M Barrier, M L Campanari, P Verwaerde

> More

News_PD.png

 PLATFORMS  March 8, 2021

 

The histology department is strengthened with the reinforcement of the team and the investment in the latest equipment.

> More

Biomek_edited.jpg